1. Anonymous (1979) VII. Dermatological needs in drugs and instrumentation. J Invest Dermatol 73:473–484
2. Gip L, Hamfelt A (1982) A new propylene-glycol-based topical preparation of betamethasone dipropionate: doubleblind evaluation of efficacy, safety and absorption. Acta Ther 8:51–62
3. Gip L, Hamfelt A (1984) Studies on the efficacy and adrenal effects of diprolene ointment 0.05 percent and dermovate ointment 0.05 percent in patients with psoriasis or other resistant dermatoses. Cutis 33:215–223
4. Goa KL (1988) Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review. Drugs 36 (Suppl V):51–61
5. Jacobsen C, Cornell RC, Savin RC (1986) A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis. Cutis 37:213–220